Pfizer sees COVID-19 vaccine revenue rise, expects to deliver 2.1 billion doses in 2021
Pfizer expects to deliver 2.1 billion doses of its COVID-19 vaccine in 2021, with plans to manufacture a total of 3 billion by the end of 2021.
Wednesday, July 28, 2021
Pfizer sees COVID-19 vaccine revenue rise, expects to deliver 2.1 billion doses in 2021
Pfizer sees COVID-19 vaccine revenue rise, expects to deliver 2.1 billion doses in 2021
Pfizer expects to deliver 2.1 billion doses of its COVID-19 vaccine in 2021, with plans to manufacture a total of 3 billion by the end of 2021.
Related Posts:
Glencore to cooperate with U.S. corruption investigation- Australia prepares to ban Huawei from 5G project over security fears
- Murdoch's Fox ups Sky bid to $32.5 billion, all eyes on Comcast
- U.S. threat of more tariffs on China hits yuan, Aussie
- India's Vistara orders Boeing, Airbus jets worth $3.1 billion in growth plan
0 comments:
Post a Comment